• SENSEX 78,079.96
    113.61 (+0.15%)
  • BANKNIFTY 57,635.25
    -250.60 (--0.43%)
  • UltraTech Cem.
    11,575.00 10,329.00(%)
  • JSW Energy
    562.05 617.30(%)
  • Urban Company
    146.00 201.00(%)
  • HDFC Bank
    724.45 722.00(%)
  • ICICI Bank
    1,406.60 1,187.55(%)
  • Reliance Industries
    1,307.10 1,250.55(%)
  • Larsen & Toubro
    4,070.00 4,440.00(%)
  • Bharti Airtel
    1,970.05 2,174.70(%)
  • Godrej Consumer
    938.90 1,308.40(%)
  • Netweb Technol.
    5,200.00 5,241.65(%)
  • Thyrocare Tech.
    594.30 342.55(%)
  • Fortis Health.
    904.95 1,105.00(%)
  • SBI
    1,073.20 798.60(%)
  • Astral
    1,599.00 1,767.95(%)
  • M & M
    3,440.00 3,840.00(%)
  • ITC
    279.50 426.50(%)
  • Cupid
    295.00 295.00(%)
  • Bajaj Finserv
    2,037.00 2,194.65(%)
  • Axis Bank
    1,215.30 1,041.30(%)
  • Solar Industries
    20,400.00 20,400.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Ind-Swift Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 7927.0
  • ISIN : INE915B01019
296.63 -3 (-1.12%)
  • As on 13 Aug 2026 (EOD)

  • Today’s Low

    284.84

  • Today’s High

    307.00

  • Open

    307.00

  • Perv Close

    300.00

  • 52W Low

    87.15

  • 52W High

    320.50

Key Indicators

  • P/E(TTM)

    38.64

  • Mar.Cap (₹Cr.)

    2,579.54

  • Div & Yield %

    0.00

  • Book Value(₹)

    157.64

  • Debt-Equity Ratio

    -1.12

  • AGM Date

    13-Aug-2026

  • EPS

    7.68

  • P/E Ratio

    38.64

Financials Ratios

  • Debt-Equity Ratio

    0.61

  • Mar.Cap (₹Cr.)

    2,579.54

  • RONW (%)

    19.32

  • ROCE (%)

    20.71

Score Board

  • Equity (₹ in Cr.)

    86.96

  • BV (₹)

    157.60

  • Sales( ₹ in Cr.)

    635.89

  • NP (in Cr.)

    50.70

  • NP Var(%)

    530.0

  • Div%

    0.0

  • CPS (₹)

    9.30

  • EPS (₹)

    5.80

  • Traded Value (₹ in Lakhs)

    2,605.37

  • 52 Week High

    320.50

  • 52 Week Low

    87.15

  • Price BSE

    300.0

  • Price NSE

    300.00

  • Market Capital( in Cr.)

    2,605.37

  • P/C Ratio

    32.10

  • P/E Ratio

    51.50

  • Price Vs.BV

    5.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 549.65 1,672.57 1,151.96 988.09 856.58 751.84
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 549.65 1,672.57 1,151.96 988.09 856.58 751.84
Other Income 304.48 479.29 33.28 42.50 23.13 36.02
Stock Adjustments 10.36 -66.92 12.34 39.47 2.48 12.44
Total Income 864.49 2,084.94 1,197.58 1,070.06 882.19 800.30
EXPENDITURE :            
Raw Materials 295.36 782.01 629.18 537.62 427.47 391.29
Power and Fuel Cost 13.72 73.61 76.07 58.40 37.31 34.65
Employee Cost 115.33 233.43 132.70 124.62 104.17 100.38
Other Manufacturing Expenses 37.50 57.15 38.53 36.51 28.76 25.73
Selling and Administration Expenses 97.07 122.77 63.98 62.17 78.98 69.66
Miscellaneous Expenses 13.97 37.86 28.40 16.22 1.87 0.62
Employee Benefit Expenses 115.33 233.43 132.70 124.62 104.17 100.38
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 572.94 1,306.83 968.85 835.54 678.56 622.32
Operating Profit 291.54 778.11 228.73 234.52 203.63 177.98
Interest 2.92 103.77 92.17 95.55 100.22 107.48
Gross Profit 288.62 674.34 136.56 138.97 103.41 70.50
Depreciation 24.48 80.41 57.36 130.97 87.29 90.06
Profit Before Tax 264.14 593.93 79.20 8.00 16.12 -19.56
Current Tax 11.88 68.60 13.36 24.62 11.04 0.41
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -3.83 -10.84 23.36 -10.92 9.48 0.82
Reported Net Profit 256.09 536.18 42.47 -5.71 -4.40 -20.79
Extraordinary Items 248.04 389.96 -13.39 -3.13 0.00 0.07
Adjusted Net Profit 8.05 146.22 55.86 -2.58 -4.40 -20.86
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -398.98 -935.16 -80.16 -74.45 -70.05 -49.26
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -142.89 -398.98 -37.69 -80.16 -74.45 -70.05
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 37.25 79.77 7.10 -0.95 -0.74 -3.48
Earnings Per Share(Adj)-Unit Curr 37.25 79.77 7.10 -0.95 -0.74 -3.48
Book Value 158.56 118.75 82.26 72.91 71.55 70.15
Book Value(Adj)-Unit Curr 158.56 118.75 82.26 72.91 71.55 70.15

Shareholding Pattern

  • Promoter Group

    42.93%

  • Public Share Holding

    57.07%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 32,882,521 37.81 32,882,521 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 4,451,757 5.12 4,451,757 19
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 37,334,278 42.93 37,334,278 20
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 76 0.00 76 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 9,305,612 10.70 9,305,612 12
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 300 0.00 300 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 146,543 0.17 146,543 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 9,452,531 10.87 9,452,531 16
2] Non Institution
Bodies Corporate 6,193,472 7.12 6,183,672 257
Clearing Members 179,949 0.21 179,949 24
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,960,806 2.25 1,960,806 522
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 992,785 1.14 992,785 942
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 18,001,120 20.70 18,001,120 124
Individuals holding nominal share capital up to Rs. 1 lakh 11,956,076 13.75 11,835,528 38,946
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 712,770 0.82 712,770 4
Sub Total 40,174,749 46.20 40,044,401 40,845
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 86,961,558 100.00 86,831,210 40,881

Company Background

Ind-Swift Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Ind-Swift Laboratories Ltd
  • BSE Code : 7927.0
  • ISIN : INE915B01019

  • Incorporation Year

    1995

  • Registered Office

    SCO 850 Shivalik Enclave
    NAC Manimajra, Chandigarh,
    Chandigarh-160101

  • Telephone

    91-0172-5061850/2730920

  • FAX

    91-0172-2730504/2736294

  • Chairman

    N R Munjal

  • Managing Director

  • Company Secretary

    Pradeep Verma

  • Auditor

    Rattan Kaur & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Alankit Assignments Ltd
    205/208,
    Anarkali Market,Jhandewalan Extn
    Mumbai - New Delhi - 110055

Ind-Swift Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Ind-Swift Labs. 296.75 630.92 549.65 43.83 1.09
Abbott India 27,617.45 7,217.19 6,929.05 37.81 43.78
Astrazeneca Phar 7,791.60 2,304.07 2,275.58 114.84 27.86
P & G Health Ltd 5,922.40 944.52 934.17 27.55 71.75
Glaxosmi. Pharma 2,664.65 3,932.76 3,790.20 42.57 58.17
Cipla 1,461.00 20,102.60 18,979.95 38.40 13.88
Bliss GVS Pharma 512.60 773.53 729.81 56.21 12.51
Amrutanjan Healt 491.85 469.50 451.82 26.34 21.89
Fermenta Biotec. 459.55 474.15 450.25 21.45 18.77
Guj. Themis Bio. 347.45 152.47 150.80 77.73 27.21
Ambalal Sarabhai 41.28 19.52 3.94 28.87 6.77